Published in Trop Med Parasitol on September 01, 1994
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev (1996) 3.26
The antimalarial drug artemisinin alkylates heme in infected mice. Proc Natl Acad Sci U S A (2005) 1.81
Status of antimalarial drugs under development. Bull World Health Organ (1995) 1.22
Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737. Antimicrob Agents Chemother (1997) 0.90
In vitro and in vivo potentiation of artemisinin and synthetic endoperoxide antimalarial drugs by metalloporphyrins. Antimicrob Agents Chemother (2000) 0.84
Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum. Lancet (1989) 3.96
The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Ann Trop Med Parasitol (1975) 3.80
Practice parameters for the treatment of sigmoid diverticulitis--supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum (2000) 2.77
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation (1997) 2.65
Climate regulation of fire emissions and deforestation in equatorial Asia. Proc Natl Acad Sci U S A (2008) 2.40
Lysosomes, pH and the anti-malarial action of chloroquine. Nature (1972) 2.18
The antimalarial activity of some quinolone esters. Ann Trop Med Parasitol (1970) 2.08
Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance. Exp Parasitol (1965) 2.01
The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Ann Trop Med Parasitol (1980) 2.00
The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice. Trans R Soc Trop Med Hyg (1987) 1.76
The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol (1978) 1.70
Arteether, a new antimalarial drug: synthesis and antimalarial properties. J Med Chem (1988) 1.69
4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1996) 1.65
Antileishmanial activity of antimonials entrapped in liposomes. Nature (1978) 1.64
The resistance of intracellular Leishmania parasites to digestion by lysosomal enzymes. Ann Trop Med Parasitol (1977) 1.57
Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B. Int J Radiat Oncol Biol Phys (1992) 1.51
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant (2000) 1.48
Antimalarial drug resistance: an increasing problem. Br Med Bull (1982) 1.45
Atrial sensing and AV synchrony in single lead VDD pacemakers: a prospective comparison to DDD devices with bipolar atrial leads. J Cardiovasc Electrophysiol (1999) 1.43
New answers through chemotherapy? Experientia (1984) 1.41
The treatment of severe falciparum malaria. Br Med J (Clin Res Ed) (1985) 1.39
The problem of drug resistance in malaria. Parasitology (1985) 1.37
Full-thickness facial chemical burn from a "50% TCA" peel. Plast Reconstr Surg (1995) 1.37
Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart (2005) 1.34
Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest (2001) 1.31
Generation of leukotrienes from human granulocytes by alveolysin from Bacillus alvei. Infect Immun (1984) 1.30
The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490). Ann Trop Med Parasitol (1977) 1.29
Isolation and characterization of amber mutations in gene dnaA of escherichia coli K-12. J Bacteriol (1981) 1.28
Plants as sources of antimalarial drugs: in vitro antimalarial activities of some quassinoids. Antimicrob Agents Chemother (1986) 1.27
An improved technique for the cultivation of Plasmodium falciparum in vitro without daily medium change. Ann Trop Med Parasitol (1985) 1.27
Antimalarial drugs and their actions. Postgrad Med J (1973) 1.26
Drug resistance in malaria--a perspective. Trans R Soc Trop Med Hyg (1969) 1.24
Uptake of [3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg (1984) 1.22
The electrical response of maize to auxins. Biochim Biophys Acta (1991) 1.21
Leishmania in the Old World: 4. The distribution of L. donovani sensu lato zymodemes. Trans R Soc Trop Med Hyg (1986) 1.20
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo. J Antimicrob Chemother (2007) 1.17
Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii. Antimicrob Agents Chemother (2000) 1.16
Theory for the mechanism of chloroquine resistance in rodent malaria. Nature (1970) 1.15
The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'. Ann Trop Med Parasitol (1984) 1.14
Leishmania in the Old World: 2. Heterogeneity among L. tropica zymodemes. Trans R Soc Trop Med Hyg (1986) 1.14
The isolation and isoenzyme characterization of Leishmania braziliensis subsp. from patients with cutaneous leishmaniasis acquired in Belize. Trans R Soc Trop Med Hyg (1984) 1.13
Fansidar in malaria prophylaxis. Br Med J (Clin Res Ed) (1985) 1.10
Thirty-month demonstration project for treatment of self-injurious behavior in severely retarded individuals. Monogr Am Assoc Ment Defic (1982) 1.10
ARDS in patients with thermal injury. Intensive Care Med (1999) 1.07
Hybrid formation within the genus Leishmania? Parassitologia (1989) 1.07
Biochemical taxonomy of Leishmania. I. Observations on DNA. Ann Trop Med Parasitol (1974) 1.07
A review of recent studies on chemotherapy and drug resistance in malaria parasites of birds and animals. Trop Dis Bull (1967) 1.06
The metabolism of leukotrienes in blood plasma studied by high-performance liquid chromatography. Biochim Biophys Acta (1985) 1.06
Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes (1990) 1.06
Plants as sources of antimalarial drugs, Part 4: Activity of Brucea javanica fruits against chloroquine-resistant Plasmodium falciparum in vitro and against Plasmodium berghei in vivo. J Nat Prod (1987) 1.05
Studies on the leishmaniases in the Sudan. 1. Epidemic of cutaneous leishmaniasis in Khartoum. Trans R Soc Trop Med Hyg (1991) 1.05
Studies on the leishmaniases in the Sudan. 2. Clinical and parasitological studies on cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1992) 1.03
The blood schizontocidal action of erythromycin against Plasmodium knowlesi infections in Macaca mulatta. Ann Trop Med Parasitol (1983) 1.02
The chemotherapy of rodent malaria, XXXIX. Ultrastructural changes following treatment with artemisinine of Plasmodium berghei infection in mice, with observations of the localization of [3H]-dihydroartemisinine in P. falciparum in vitro. Ann Trop Med Parasitol (1985) 1.02
The experimental chemotherapy of leishmaniasis. I: Techniques for the study of drug action in tissue culture. Ann Trop Med Parasitol (1975) 1.02
The chemotherapy of rodent malaria. IX. Causal prophylaxis. I. A method for demonstrating drug action on exo-erythrocytic stages. Ann Trop Med Parasitol (1970) 1.02
Recent advances in antimalarial chemotherapy and drug resistance. Adv Parasitol (1974) 1.00
Infectivity of chloroquine resistant Plasmodium berghei to Anopheles stephensi enhanced by chloroquine. Nature (1969) 0.99
Partial inhibition by mepacrine of the development of sulphonamide resistance in Plasmodium berghei. Nature (1969) 0.99
Phlebotomus sergenti, a vector of Leishmania tropica in Saudi Arabia. Trans R Soc Trop Med Hyg (1988) 0.98
The mouse Ptprr gene encodes two protein tyrosine phosphatases, PTP-SL and PTPBR7, that display distinct patterns of expression during neural development. Eur J Neurosci (1999) 0.98
A review of the literature on the etiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesthetic Plast Surg (1999) 0.97
The effect of cytotoxic agents on autophagic vacuole formation in chloroquine-treated malaria parasites (Plasmodium berghei). Life Sci II (1971) 0.97
The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes. Ann Trop Med Parasitol (1986) 0.97
The treatment of kala-azar--new approaches to an old problem. Indian J Med Res (1981) 0.96
Tissue- and cell-specific distribution of creatine kinase B: a new and highly specific monoclonal antibody for use in immunohistochemistry. Cell Tissue Res (1995) 0.96
Preliminary serological characterization of bovine viral diarrhoea virus strains using monoclonal antibodies. Vet Microbiol (1986) 0.96
Zoonotic cutaneous leishmaniasis in Saudi Arabia: the incrimination of Phlebotomus papatasi as the vector in the Al-Hassa oasis. Trans R Soc Trop Med Hyg (1985) 0.96
Clostridium septicum abscess in hepatic metastases: successful medical management. Bone Marrow Transplant (1994) 0.95
Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Trop (2001) 0.95
Comparative electron microscope study of pellicular structures in coccidia (Sarcocystis, Besnoitia and Eimeria). Int J Parasitol (1977) 0.95
High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. J Clin Oncol (1986) 0.95
The chemotherapy of rodent malaria. XI. Cyclically transmitted, chloroquine-resistant variants of the Keyberg 173 strain of Plasmodium berghei. Ann Trop Med Parasitol (1970) 0.95
Leishmania in the Old World: 1. The geographical and hostal distribution of L. major zymodemes. Trans R Soc Trop Med Hyg (1986) 0.94
The chemotherapy of rodent malaria, XXVII. Studies on mefloquine (WR 142,490). Ann Trop Med Parasitol (1977) 0.94
The chemotherapy of rodent malaria, XXXII. The influence of p-aminobenzoic acid on the transmission of Plasmodium yoelii and P. berghei by Anopheles stephensi. Ann Trop Med Parasitol (1980) 0.94
The experimental chemotherapy of leishmaniasis. II. The activity in tissue culture of some antiparasitic and antimicrobial compounds in clinical use. Ann Trop Med Parasitol (1975) 0.94
Preventive effect of artemether in experimental animals infected with Schistosoma mansoni. Parasitol Int (2000) 0.93
Effects of qinghaosu and related compounds on incorporation of [G-3H] hypoxanthine by Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg (1983) 0.93
Preserved autonomic modulation of the sinus and atrioventricular nodes following posteroseptal ablation for treatment of atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol (1998) 0.93
On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis (1995) 0.93
Cellular mechanisms of differential action potential duration restitution in canine ventricular muscle cells during single versus double premature stimuli. Circulation (1992) 0.93
The antimalarial activity of N-benzyl-oxydihydrotriazines. III. The activity of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(2,4,5,-trichloropropyloxy)-1,3,5-triazine hydrobromide (BRL 51084) and hydrochloride (BRL 6231). Ann Trop Med Parasitol (1982) 0.93
The chemotherapy of rodent malaria, XXVI. The potential value of WR 122,455 (a 9-phenanthrenemethanol) against drug-resistant malaria parasites. Ann Trop Med Parasitol (1976) 0.92
Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis. Eur J Immunol (2001) 0.92
The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis. Ann Trop Med Parasitol (1980) 0.92
Rapid action of Qinghaosu and related drugs on incorporation of [3H]isoleucine by Plasmodium falciparum in vitro. Biochem Pharmacol (1983) 0.92
The experimental chemotherapy of leishmaniasis, VII. Drug responses of L. major and L. mexicana amazonensis, with an analysis of promising chemical leads to new antileishmanial agents. Ann Trop Med Parasitol (1980) 0.92
Malaria of the orang-utan (Pongo pygmaeus) in Borneo. Philos Trans R Soc Lond B Biol Sci (1976) 0.91
Qinghaosu resistance in rodent malaria. Trans R Soc Trop Med Hyg (1986) 0.91
The experimental chemotherapy of leishmaniasis, IV. The development of a rodent model for visceral infection. Ann Trop Med Parasitol (1980) 0.91
The chemotherapy of rodent malaria. XVII. Dynamics of drug resistance. 3. Influence of drug combinations on the development of resistance to chloroquine in P. berghei. Ann Trop Med Parasitol (1973) 0.91
[Cultivation of exo-erythrocytic schizonts of rodent Plasmodium in hepatocytes: a new experimental model for chemotherapy of malaria]. C R Acad Sci III (1985) 0.91
Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block? Eur Heart J (2001) 0.90
Malaria parasites of the orang-utan (Pongo pygmaeus). Ann Trop Med Parasitol (1972) 0.90
Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737. Antimicrob Agents Chemother (1997) 0.90
Advances in malariology relating to control and eradication. Br Med Bull (1972) 0.90
Artemether administered together with haemin damages schistosomes in vitro. Trans R Soc Trop Med Hyg (2001) 0.90
Impact of breast carcinoma on African-American women: the Detroit experience. Cancer (2001) 0.89
Malaria vaccination: two steps forward, one backward. Br Med J (Clin Res Ed) (1983) 0.89